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Abstract: The encapsulation of folded proteins in stabilizing 
matrices is one of the challenges of soft matter material sciences.  
Capturing such fragile biomacromolecules from aqueous solution, 
and embedding them in a lattice that stabilizes them against 
denaturation and decomposition is difficult.  Here we report that 
tetrahedral oligonucleotide hybrids as branching elements and 
connecting DNA duplexes with sticky ends can assemble into 
materials.  The material-forming property was used to capture DNA-
binding proteins selectively from aqueous protein mixtures.  The 
three-dimensional networks also encapsulate guest molecules in 
size-selective manner, accommodating proteins up to a molecular 
weight of approx. 10 kDa for the connecting duplex lengths tested.  
Exploratory experiments with green fluorescent protein showed that, 
when embedded in the DNA-based matrix, the protein is more stable 
toward denaturation than in free form, retaining its luminescent 
properties for at least 90 days in dry form.  The non-crystalline 
biohybrid matrices presented here may be used for capturing other 
proteins or for producing functional materials.   
Introduction 
Protein-nucleic acid complexes are important for the cell.[1,2,3]  
Nature uses proteins for packaging DNA or RNA to prevent its 
decomposition, e.g. in sperm cells [4,5] or virus assemblies, such 
as tobacco mosaic virus.[6]  In the complex, the genetic material 
sometimes survives for years.  Packaging proteins is an 
interesting challenge for which different approaches are being 
proposed.[7,8,9]  It is important to meet this challenge, e.g. for 
capturing enzymes when they have finished catalyzing the 
biotransformation that they were supposed to induce.  Often, 
remaining enzymes will destabilize a bioproduct, if not removed 
or captured.  Likewise, recycling the enzyme can facilitate 
production and can reduced the cost of biotechnological 
processes.[10,11]  So, there is a need for capturing, packaging, 
protecting and releasing proteins.  Ideally, an approach for doing 
so should involve a non-toxic material that assembles into an 
encapsulating lattice of tunable dimension.  If one was to use 
DNA as packing material to stabilize proteins, this would be an 
"inverse" approach to the packaging of genetic material in nature, 
mentioned above. 
Given the incentives, it is not surprising that encapsulating 
proteins in a designed three-dimensional matrix is a long-
standing goal of DNA nanotechnology.  Encapsulation was 
expected to facilitate structure elucidation.  The use of DNA 
lattices for this purpose was first proposed by Seeman in 
1982,[ 12 ] and Seeman's proposal to use DNA for arraying 
proteins three-dimensionally is often seen as the starting point of 
DNA nanotechnology as a field.  Possible solutions to the 
protein encapsulation challenge include DNA nanocages[13] and 
channels in DNA crystals. Different DNA crystals with 
continuous lattices formed by base pairing have been described.  
Crystals with hexagonal lattice geometry were found to form 
through self-assembly of a DNA tridecamer that engages in both 
canonical and parallel base pairing.[14]  Another type of crystals 
contains designed lattices, with cohesion of the folding motifs via 
sticky ends.[15,16,17]  Crystals of the former type have been shown 
to act as molecular sieves for proteins, with an adsorption cut-off 
of approx. 45 kDa.[18]  Further, a small enzyme, ribonuclease A, 
was found to hydrolyze dinucleotides as substrates when 
captured in DNA crystals.[ 19 ]  Finally, DNA hydrogels with 
encapsulated insulin have been shown to act as slow-release 
formulations.[20] 
 
Figure 1. Cartoon representation of a process for capturing proteins in 
designed three-dimensional lattices, formed by oligonucleotides and 
connecting DNA duplexes.  No highly ordered, crystalline structure is required 
for capturing proteins in such reticular networks.   
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While the known nucleic acid-protein complexes indicate that 
DNA is suitable for protein encapsulation, no products that make 
use of the encapsulation approaches mentioned above have yet 
entered the market.  Since crystallization is slow, and long DNA 
is expensive to produce on a large scale, there is room for 
alternative approaches.  Synthetic compounds that utilize rigid 
cores and the predictable pairing properties of short DNA arms 
and that can be produced via efficient syntheses are one 
attractive approach.   
We have recently reported branched oligonucleotide hybrids 
with tetraaryladamantane cores that readily assemble into 
materials when their CG dimer arms are allowed to hybridize in 
dilute aqueous solution.[21,22]  Solution-phase syntheses that are 
based on phosphoramidites[ 23 , 24 ] or H-phosphonates[ 25 ] were 
established that make these compounds inexpensive 
alternatives to constructs that are based on linear DNA strands.  
The propensity of hybrids to self-assemble can be tuned through 
changes in the structure of the organic core.[ 26 ]  Expanded 
versions of such hybrids containing triplex binding motifs have 
been developed for capturing cofactors.[27]  However, the pore 
size of the materials formed by the self-assembling hybrids with 
short sticky ends are too small to accommodate proteins.   
Here we report the encapsulation of proteins in self-assembling 
matrices made up of branched oligonucleotide hybrids and 
connecting duplexes (Figure 1).  The connecting duplexes allow 
for an adjusting of the size of the cavities in the three-
dimensional lattices.  Capture of DNA-binding proteins with 
affinity for the connecting duplex, and size-specificity for non-
DNA-binding protein guest molecules were demonstrated.  
Macroscopic quantities of hybrid biomaterials are readily 
obtained and stabilization against denaturation was 
demonstrated by encapsulating green fluorescent protein (GFP).  
Results and Discussion 
Our encapsulating material was to be formed through self-
assembly, with the adamantane-based branched oligonucleotide 
hybrids as the junction nodes that link connecting DNA duplexes 
in the three-dimensional lattices.  For this, we first synthesized a 
new hybrid with tetramer arms, building upon our methodology 
for the synthesis of dimer H-phosphonate strands.[25]  An 
overview of the synthetic elaboration of the H-phosphonate-
terminated tetramer chain is shown in Scheme 1.  The DNA 
sequence TCCC was chosen in order to obtain sufficiently stable 
duplexes with GGGA overhangs of connecting duplexes.  
Protected tetramer 1 was obtained in an overall yield of 61% on 
a gram scale without chromatography over 6 synthetic steps, as 
detailed in the Supporting Information (SI).  With this tetramer H-
phosphonate, we then assembled hybrid 2, using tetrakis(p-
hydroxybiphenyl)adamantane (TBA) as core and a modification 
of the coupling methodology described for hybrids with shorter 
arms.[25,26]  
 
We then proceeded to testing whether hybrid 2 and DNA 
duplexes with complementary single-stranded overhangs form 
detectable assemblies and/or a macroscopically visible material.  
To induce assembly, the self-complementary DNA strands were 
first denatured using heat and alkaline conditions to break down 
any existing secondary structures, and subsequently allowed to 
pair by neutralizing with AcOH, addition of phosphate buffer 
(final concentration 10 mM, pH 7) and 1 M NaCl, and cooling at 
a rate of 0.5 °C/min.  Duplex formation was monitored by UV-
absorption (Figure S5, Supporting Information).   
 
 
Scheme 1.  Solution-phase synthesis of oligonucleotide hybrid (TCCC)4TBA (2) and sequences of selected connecting duplexes, other sequences are shown in 
Table 1.  a) ACN, pyr-TFA, t-BuOOH and DCA/H2O; b) DMF/ACN, pyr-TFA, t-BuOOH and DCA/H2O; c) DMF/ACN, pyr-TFA and t-BuOOH.   
After reaching the final temperature of 5 °C, hybrid 2 was added 
at a molar ratio of 1:2, (hybrid/duplex).  At defined time intervals, 
absorption spectra were recorded at 5 °C for 2:(9)2, 2:(12)2, and 
2:(17)2 (Figures S5 and S6; SI). Duplex-mediated lattice 
  
 
 
formation was usually complete after 48 h. The kinetics 
depended on the length of the duplex in a non-trivial way, which 
may be due to topological issues. The absorption measurements 
in the supernatants showed that on average approx. 57% of the 
compounds precipitated under the conditions chosen.   
 
Figure 2. Compositional analysis of solid formed from 2 and connecting 
duplex (15)2 upon annealing of the linear strands, adding 2, assembling at 
4 °C, isolating the precipitate, and washing. A sample of the solid was 
dissolved in hot deionized water and analyzed by HPLC (shown on the left) 
and MALDI-TOF mass spectrometry of the fractions (shown on the right).   
Figure 3.  Additional sequences used for connecting duplexes.   
Connecting duplexes with lengths ranging from 6 to 18 base 
pairs, equipped with GGGA overhangs were used. The duplexes 
are all at least 2 nanometers in length, as required for nanoscale 
lattices.  All gave visible material at the end of the assays (Table 
1). When samples were isolated and analyzed by HPLC and 
MALDI-TOF mass spectrometry, the analysis confirmed that the 
solids were composed of the hybrid and the duplex.  Figure 2 
shows a representative result for the solid formed from 2 and 
connecting duplex (15)2, and Table 1 lists other data.   
Assays were also carried out at a high concentration of duplex 
and hybrid (up to 330/165 µM). In each case, the material 
formed was isolated, washed, and analyzed via HPLC to 
determine its composition. A perfect lattice should contain 
duplexes and hybrids at a ratio of 2:1. The chromatograms 
showed that the materials consisted of the components at a ratio 
of 1.8-2.5/1 (duplex/hybrid), in reasonable agreement with the 
ideal stoichiometry of the lattice.  The formation of large 
assemblies manifested itself in a hysteresis between heating 
and cooling transitions in UV-monitored analyses (see Figure S8, 
SI for a representative example). Taken together, these results 
suggested that assembly of hybrids and duplexes into three-
dimensional networks is a robust process.   
 
The DNA-based lattices were designed to offer cavities for 
harboring guest molecules of the size of protein enzymes. We 
therefore proceeded to studying the encapsulation of proteins in 
those lattices.  For this, the salt concentrations in the assembly 
assay were lowered to be closer to physiological ionic strength.  
Here, assays were performed at 150 mM NaCl and ≤ 10 mM 
MgCl2.  Initially, we used small DNA-binding protein domains to 
test the capturing capabilities of the lattices.  In order to further 
reduce the likelihood of possible hairpin structures that could 
inhibit the growth of the lattice, complementary DNA strands 
were used, rather than one self-complementary sequence.  Four 
different connecting duplexes were used, namely 23:24, 25:26, 
27:28, and 29:30 (Figure 3). Lattice formation was again initiated 
by addition of hybrid 2 and was monitored by absorption 
measurements. Figure 4a shows representative results. When 
both 2 and a full connecting duplex were present, the formation 
of a lattice was observed in a time-dependent manner.  When 2 
and just one of the two strands, without the complementary 
strand, were used, no material formed.   
Table 1. Formation of solids upon assembly of hybrid 2 and connecting duplexes of different length into networks, as monitored by UV-absorption. 
Entry No DNA strand 
Duplex 
[μM] 
Hybrid 
[μM] 
buffer Fraction precipitated (%) 
Compound ratio 
in solid (duplex/hybrid) 
1 -- - 35 
A[a] 
-- -- 
2 5'-GGGA-CGATCG-3' (9) 69 35 54 1.4 / 1 
3 5'-GGGA-GCGATCGC-3' (10) 36 18 28 1.8 /1 
4 5'-GGGA-TGCGATCGCA-3' (11) 63 31 45 1.8 / 1 
5 5'-GGGA-CTGCGATCGCAG-3' (12) 39 19 57 2.5 / 1 
6 5'-GGGA-GACTGCGATCGCAGTC-3' (13) 32 16 34 2.1 / 1 
7 5'-GGGA-ACCAAGGCGATCGCCTTGGT-3' (14) 69 35 55 2.3 / 1 
8 5'-GGGA-ACTGTAATTACAGT-3' (15) 263 132 
B[b] 
66 1.5/1 
9 5'-GGGA-GATTATGATCATAATC-3' (16) 310 155 66 2.2/1 
10 5'-GGGA-CGACTATAATTATAGTCG-3' (17) 317 158 67 2.5/1 
11 5'-GGGA-ACCATATAATATTATATGGT-3' (18) 167 83 58 1/1 
12 5'-GGGA-AACGAT-3' (19), 5'-GGGA-ATCGTT-3' (20) 330 165 85 2.1/1 
13                                     19:20 333 -- -- -- 
14 5'-CCCT-AACGAT-3' (21), 5'-CCCT-ATCGTT-3' (22) 333 167 -- -- 
15                                     21:22 333 -- -- -- 
[a] Carried out in Assembly Buffer A; 10 mM phosphate buffer, 1 M NaCl);  [b] Assembly Buffer B; 10 mM HEPES, 1 M NaCl.   
At the salt concentration chosen, slightly less material 
precipitated than in the experiments with the self-complementary 
sequences.  Still, lattice formation was strong enough to proceed 
to encapsulation tests with proteins.  For this, after annealing of 
the linear DNA duplexes, either the DNA-binding protein 
  
 
 
CxxC,[28,29,30] or aldolase, a small metabolic enzyme were added, 
followed by the addition of 2.   
 
 
Figure 4.  Kinetics of the formation of solids upon assembly into three-
dimensional lattices, as detected by UV-absorption at 260 nm, after addition of 
hybrid 2.  a) Hybrid 2 and connecting duplexes formed from pairs of 
complementary strands of different length.  The total duplex length is as 
defined in Figure 5.  b)  Kinetics of formation of solids upon assembly into 
three-dimensional networks, without any protein, with CxxC, or with aldolase, 
as monitored by the decrease in absorbance; c) absorption of solutions of 
controls.  Conditions: 3 µM strands, 1.5 µM 2, 0.3 µM protein in 20 mM 
HEPES buffer, 150 mM NaCl and 10 mM MgCl2.   
The solutions showed a drop in absorption of up to 35% for both 
CxxC and aldolase under these condition (1.5 µM hybrid 2, 3 µM 
duplex 23:24 and 0.3 µM protein) after an incubation time of 48 
h (Figure 4b). The kinetics of assembly were similar to those 
found for the assembly of the DNA components alone, 
suggesting that interactions driving network formation are DNA-
DNA interactions, not interactions between oligonucleotides and 
proteins.  The control experiments, in which the hybrid was left 
out, showed no change in absorption (Figure 4c).  After the 
composite material had assembled, as shown in Figure 4b, 
some samples were slowly heated to 85°C.  The results from 
this thermal analysis indicate that the lattices start to re-dissolve 
at approx. 35 °C (Figure S7, SI). The melting curves also 
showed more than one transition when proteins were 
encapsulated, as expected for assemblies with a more complex 
morphology than that of duplexes and hybrid alone.   
The next experiments on protein encapsulation used CxxC (11 
kDa) and Mbd2[ 31 ,32 ,33 ] (10 kDa), another small DNA-binding 
protein with a different specificity.  Connecting duplexes 
consisted of strands 31-47 (Figure 3).  This group of duplexes 
included sequences containing a CG dinucleotide featuring 
either 5-methylcytosine (mCG) or unmethylated cytosine (CG).  
The former is a recognition motif for Mbd2, and the latter for 
CxxC. Material formation in the presence of increasing 
concentrations of the proteins was studied.  The solids obtained 
were separated from the mother liquor by centrifugation and 
extensively washed with buffer to remove unentrapped proteins.  
The composition of the liquid and the solid fractions was 
determined by gel electrophoresis.  We observed high yields of 
encapsulation of either of the DNA binding proteins in the solid 
(Figure S9, SI).  The gel analysis of the solids showed that the 
DNA-binding proteins were encapsulated (Table S1 and Figure 
S9, SI).  Uptake of up to 90% was achieved under these 
conditions (20 mM HEPES, 150 mM NaCl and 10 mM MgCl2).  
The selectivity of CxxC and Mbd2 for their cognate sequences 
was modest, though, suggesting that at the concentrations 
chosen, both proteins had sufficient affinity for the DNA 
duplexes. 
This prompted us to test whether the lattice formed by 
connecting duplexes and 2 can capture proteins without 
significant affinity for DNA, by simple physical entrapment.  This 
entrapment was expected to be size-limited, and proteins too 
large to fit into the pores of the three-dimensional network were 
expected to be selected against.  To test this, we used a set of 
proteins with sizes ranging from 12 kDa (cytochrome C) to 529 
kDa for (ferritin complex), as shown in Figure 5.  The diameters 
of the proteins range from 3.8 nm to 13 nm.  The proteins used 
in the entrapment experiments were expected not to interact 
strongly with DNA electrostatically or via a specific complex.  
 
  
 
 
 
Figure 5.  Structure of components employed in encapsulation assays, roughly drawn to scale.  For proteins, the structures were generated from pdb entries 
2KY834 (Mbd2, 3.7 nm /10 kDa), 4NW335 (CxxC, 3.2 nm /11 kDa), 5TY336 (cytochrome c, 3.8 nm /12 kDa), 1GFL37 (GFP, 3,8 nm /27 kDa), 2CAB38 (carbonic 
anhydrase, 4.3 nm /29 kDa), 4LUF39 (albumin, 8.3 nm /68 kDa), 1ALD40 (alodlase, 11 nm /159 kDa), 1FA241 (amylase, 12 nm /226 kDa), and 1LB342 (ferritin, 13 
nm /529 kDa). For double-stranded DNA, a canonical B-form duplex was generated in Maestro, version 7.5.106, for hybrid 2, an energy minimized structure 
generated in Chem3D Pro, version 14.0 is shown.  The latter two graphics were generated in VMD.[43]   
Table 2. Results from encapsulation assays with proteins of different size.  
    Encapsulation (%)a 
protein 
diameter 
(nm) 
Molecular 
weight 
(kDa) 
total 
duplex 
lengthb 
14 bp 
(19:20) 
20 bp 
(23:24) 
conc. 
2 
[µM]c 
27 20 20 30 
cyctochrome C 3.8 12  28 29 26 29 
GFP 3.8 27  n. d. 16 30e 
carbonic 
anhydrase 
4.3 29  12 16 8 15 
albumin 8.3 68  23 28 17 19 
aldolase 11 159  22 12 46 34 
β-amylase 12 226  14 5 4 < 5 
ferritin 13 529  <7 <2 <2 <10 
a) As determined by integration of band intensities in SDS PAGE of 
supernatant and material fractions; b) as defined in Figure 5;  c) connecting 
duplex strands at twice the concentration of the hybrid, as required by the 
stoichiometry of the 3D lattice. d) GFP encapsulation was performed with the 
self-complementary strand GGGAACTGTAATTACAGT (15) as connecting 
duplex;  e) at a hybrid concentration of 39 µM.   
Encapsulation of the proteins showed a size dependence 
reminiscent of that of gel permeation or size exclusion 
chromatography, albeit at much larger sizes than in GPC.  Small 
proteins were entrapped, whereas proteins with sizes above the 
lattice dimensions were excluded from the matrix formed upon 
assembly.  The size exclusion correlated with the length of the 
connecting DNA duplexes.  The upper limit for the lattice with 
23:24 as connecting duplex was approx. 159 kDa, and with the 
duplex 19:20 it was approx. 68 kDa, with aldolase no longer 
being well accepted into the three-dimensional network.  The 
comparison of the trapping efficiency of CxxC and Mbd2 versus 
those of the non-DNA binding proteins, shows that the DNA 
binding proteins are more efficiently encapsulated in the DNA 
material in this experiments, as expected due to their affinity for 
the duplexes.  
For biotechnological or biomedical applications, it is interesting 
to stabilize enzymes against denaturation and degradation, and 
to preserve their integrity and function during storage and 
transport.  To see whether such an effect can be achieved with 
our lattices, we performed exploratory tests with purified 
recombinant green fluorescent protein (GFP).  Here, the integrity 
of the protein can be monitored by its fluorescence, which 
simplifies analysis.  When GFP was encapsulated in the DNA 
lattices, it remained strongly fluorescent.  In contrast to the 
uncoated control sample, which turned non-fluorescent within 
  
 
 
one day, the solid with encapsulated GFP remained fluorescent 
over more than three months, when left on the bench under 
ambient condition, suggesting that the DNA lattice protects the 
protein against unfolding and decomposition (Figure 6).   
 
Figure 6.  Microscopic photographs of GFP encapsulated in the DNA lattice, 
a) shortly after isolation of the material, and b) after 11 days at room 
temperature, and c) non encapsulated GFP at the same time points under the 
same storage conditions.   
Most probably, the composites formed from the DNA-based 
lattice and the proteins trap substantial amounts of hydration 
water, helping to preserve the native state, even when allowed 
dried. The DNA scaffold may inhibit unfolding, together helping 
to explain the high stability of the encapsulated GFP, compared 
to an unentrapped one, which probably denatured quickly when 
the sample was left to dry. Taken together, the results suggest 
that our encapsulation method produces a solid that has the 
potential to stabilize sensitive folded proteins, even when 
allowed to dry, upon exposure to air at room temperature. 
The elucidation of structural details of our reticular networks is a 
challenge that will not be easy to match.  We do not assume that 
the DNA-based lattices have crystalline order.  But, the 
formation of macromolecular assemblies manifests itself readily 
in a hysteresis between heating and cooling curves in UV-
melting transitions, as shown for a sample of hybrid 2 and 
connecting duplex (9)2 in Figure S8 of the Supporting 
Information.  This type of analysis can be performed on the time 
scale of hours, and does not require special equipment or 
crystallization set-ups.   
Conclusions 
Here we report a novel DNA-based, nano-structured material 
with cavities large enough to harbor proteins as molecular 
guests.  The size of the cavities in this material can be tuned by 
using appropriate connecting duplexes.  Both those duplexes 
and the branched oligonucleotide hybrid 2 are readily accessible 
by organic synthesis. When the lattices form, they have a 
modest and tunable propensity to precipitate from aqueous 
buffer, which allows for the capturing of proteins.  Both DNA-
binding and non-DNA binding proteins were encapsulated in our 
study, the former with higher efficiency, as expected for 
interactions beyond simple physical entrapment.  Protein 
entrapment depends on size, making the lattices selective and 
the process potentially useful for purification.  Under optimized 
conditions, the DNA binding proteins CxxC and Mbd2 were 
harvested almost quantitatively from solution. Through 
encapsulation, proteins may be protected from thermal 
denaturation and other processes that render them inactive 
when exposed to air, as demonstrated for GFP.  Since the lattice 
can be dissociated by gentle warming, the material also has the 
potential to act as controlled release medium.  Given the 
versatility of the design and its unique properties, we expect the 
hybrid lattices with their tunable lattice constants to be useful for 
practical applications. 
Experimental Section 
Encapsulation.  The following protocol is representative.  A mixture of 
solutions of strand 23 (25 µL, 8 nmol, 5'GGGA-CTGAACGATTAG-3'), 
strand 24 (27 µL, 8 nmol, 5'GGGA-CTAATCGTTCAG-3'), water (82 µL), 
HEPES buffer (20 mM, 6 µL of 0.5 M stock solution) and NaCl (150 mM, 
4.5 µL of 5 M stock) was placed in a polyropylene microtube.  
Hybridization was induced by heating to 85 °C and cooling to 4 °C in 8 h.  
Then, the protein Mbd2 (0.3 µL, 0.3 nmol) in elution buffer was added, 
mixed, and the sample was incubated for 30 min at 4 °C.  A solution of 
hybrid 2 (4.2 µL, 4 nmol) was added, and the mixture was kept at 4 °C for 
30 min, followed by the addition of 10 mM MgCl2 (1.5 µL of a 1M stock 
solution).  The sample was stored at 4 °C for 48 h.  The solid was then 
separated from the supernatant by centrifugation (4 °C, 30 min, 21500 g).  
The supernatant was removed, and the solid was washed with cold 
buffer (100 μL; 20 mM HEPES, 150 mM NaCl, 10 mM MgCl2), and 
centrifuged again.  The supernatant was again aspirated and the material 
harvested.   
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 1. General  
Chemicals.  Unless otherwise noted, reagents and solvents were obtained from commercial 
suppliers and used without further purification.  Unmodified oligonucleotides were purchased 
from Biomers (Ulm, Germany), Eurofins (Ebersberg, Germany), or IDT (Leuven, Belgium) in 
HPLC-purified form, and their integrity was confirmed by MALDI-TOF mass spectrometry. 
Chromatography.  RP-HPLC chromatography was performed on a Nucleosil C18 column (5 
μm, 250 x 4.6 mm) from Macherey-Nagel (Düren, Germany).  Column chromatography was 
performed on silica gel 60 (0.040-0.063 mm particle size).  Thin layer chromatography was 
performed on aluminum sheets, coated with silica gel 60 F254 and visualized with UV light 
(254 nm).  Mass spectrometry.  MALDI-TOF mass spectra were measured in linear negative 
mode with a matrix/comatrix mixture of 2,4-6-trihydroxyacetophenone/diammonium citrate 
on a microFlex mass spectrometer (Bruker Daltonics).  Other analytica methods.  UV-
melting curve experiments were performed on a Lambda 25 spectrophotometer (Perkin 
Elmer), using the software TempLab 2.0.  NMR spectra were recorded on Bruker AVANCE 
300, 400 or 700 spectrometers.   
 2. Synthetic route to 1 
 
Overview over the synthesis of tetramer H-phosphonate 1 
 
 
Scheme S1.  Synthesis of H-phosphonate tetramer 1.  CE = cyanoethyl.   
 2.1 Synthesis of N
4
-benzoyl-2′-deoxycytidine-3′-yl H-phosphonate (3).S1    
 
 
 
The following is a slight modification of a published procedure.
S1
 A solution of 
phosphoramidite 2c (5 g, 6 mmol) in CH3CN (20 mL), H2O (216 μL, 12 mmol, 2 equiv) and 
pyridinium trifluoroacetate (2.54 g, 13.2 mmol, 1.1 equiv) was shaken for 10 min at room 
temperature.  Subsequently, tert-butylamine (10 mL) was added, and the reaction mixture was 
stirred for 15 min.  The mixture was then concentrated in vacuo.  The residue was dissolved in 
CH2Cl2 (5 mL) and concentrated again to give a foam.  This process was repeated twice.  For 
the detritylation, the residue was dissolved in CH2Cl2 (24 mL), followed by the addition of 
H2O (600 μL) and dichloroacetic acid in CH2Cl2 (35 mL, 6% w/w).  After 10 min, the 
reaction was quenched with CH3OH (15 mL) and the solution was concentrated in vacuo to a 
small volume (10 mL).  The crude product was then precipitated by addition of tert-butyl 
methyl ether (40 mL) followed by centrifugation, and the supernatant was aspirated.  The 
solid was redissolved in CH2Cl2/CH3OH (2/1, v/v, 5 mL), and precipitated again by the 
addition of tert-butyl methyl ether (45 mL). After separation by, this process was repeated 
twice.  The remaining solid was dissolved in H2O (20 mL) and washed with ethyl acetate (30 
mL).  The organic phase was back extracted with water (2 × 10 mL) and the combined 
aqueous phases were evapored via lyophilization.  The H-phosphonate 3 was thus obtained in 
a yield of 2.11 g (4.5 mmol, 75%) as an off-white solid.  The analytical data were in 
agreement with the literature.
S1
  
31
P NMR (121.5 MHz, DMSO-d6): δ = 0.13 ppm.   
 2.2 Synthesis of H-phosphonate dimer 4. 
The H-phosphonate 3 (2.1 g, 4.5 mmol, 1.0 equiv.) was dried together with 2c (4.5 g, 5.4 
mmol, 1.2 equiv) and molecular sieves 3 Å (5-7 beads) for 2 h at 45 °C and 0.001 mbar.  The 
flask was flushed with argon, sealed with a septum, and dry CH3CN (15 mL) was added, 
followed by pyridinium trifluoroacetate solution (1 M in CH3CN, 6.5 mL, 1.2 equiv), 
previously dried over molecular sieves, 3 Å, 10 beads).  The mixture was placed in an 
ultrasonic bath for 1 min to obtain a clear solution of the starting materials.  The reaction 
mixture was then shaken for 45 min at 25 °C, and then cooled to 0 °C.  After the addition of 
tert-butyl hydroperoxide (2.7 mL, 5.5 M in decane, 15.1 mmol, 2.8 equiv.), the reaction 
mixture was allowed to reach room temperature within 30 min.  Subsequently, a mixture of 
aqueous phosphate buffer (0.2 M, pH 7) and brine (60 mL, 1:1, v/v) was added to the mixture, 
and the solution was extracted with CH2Cl2 (80 mL).  The aqueous phase was separated, and 
back-extracted with CH2Cl2 three times (3 × 30 mL).  The combined organic phases were 
dried over molecular sieves (3 Å, 20 beads), filtered and concentrated under reduced pressure.  
The residue was then dissolved in dioxane (20 mL) and separated from the remaining solid, 
which was washed twice with dioxane (2 x 5 mL).  The combined organic phases were 
concentrated under reduced pressure to approx. 10 mL, and split into 5 mL portions, followed 
by precipitation by adding MTBE (45 mL) and centrifugation (3500 rpm, 5 min).  The 
supernatant solution was aspirated , and this procedure was repeated four times.  The resulting 
solid was dissolved in dioxane (10 mL), frozen with liquid N2, and then reduced to dryness 
under vacuum (<0.001 mbar).  Compound 4 was obtained as a colorless solid in a yield of 5 g 
(4.4 mmol, 97%). 
 
31
P NMR (121.5 MHz, DMSO-d6): δ = 0.17, -2.50, -2.66 ppm (mixture of diastereomers); 
ESI-TOF m/z calcd for C56H55N7O16P2 [M-H]
-
 1142.3, obsd 1142.3.   
 
2.3 General Protocol A (Detritylation of H-phosphonate-terminated strands). 
For the detritylation of 4 or 6 (0.34 mmol), the starting material was dissolved in CH2Cl2 (4 or 
6 mL, respectively), followed by the addition of H2O (100 μL) and a solution of 
dichloroacetic acid in CH2Cl2 (6 mL, 6% w/w).  The reaction mixture was shaken for 10-15 
min at 25 °C.  After 10-15 min, the reaction was quenched with MeOH (4 mL), and the 
mixture was concentrated in vacuo to a volume of approx. 5 mL.  The product was then 
precipitated by addition of tert-butyl methyl ether (40 mL), followed by centrifugation 
(rpm/min), and the supernatant was aspirated.  The solid was redissolved in CH2Cl2/CH3OH 
(1/1, v/v, 2 mL), and precipitated again by the addition of tert-butyl methyl ether (45 mL).  
This purification procedure was repeated one more time, and the resulting solid was 
suspended in dioxane (6 mL) and then frozen with liquid N2 and dried under high vacuum 
(<0.001 mbar). 
 
2.4 General Protocol B (Synthesis of trimer or tetramer H-phosphonates). 
The detritylated H-phosphonate building block (5 or 7, 2.1 g, 1.62 mmol) was combined with 
2c or 2t (2.1 mmol, 1.3 equiv.) and dried together with molecular sieves 3 Å (10 beads) for 2 
h at 45 °C and 0.001 mbar.  The flask was flushed with argon, sealed, and DMF (2.3 mL) was 
added, followed by pyridinium trifluoroacetate solution (1 M in CH3CN, 2.74 mL, 1.3 equiv, 
previously dried over molecular sieves).  The mixture was exposed to an ultrasonic bath for 2 
min, resulting in a clear solution.  The reaction mixture was then shaken for 50 min at 25 °C 
and then cooled to 0 °C, followed by addition of tert-butyl hydroperoxide (1.07 mL, 5.5 M in 
decane, 5.9 mmol, 2.8 equiv).  The reaction mixture was shaken for 30 min at 25 °C.  A 
mixture of aqueous phosphate buffer (0.2 M, pH 7) and brine (60 mL, 1:1, v/v) was added to 
the reaction mixture, followed by extraction with CH2Cl2 (60 mL).  The phases were 
separated after centrifugation (2500 rpm, 5 min.).  The aqueous phase was back-extracted 
with CH2Cl2 (3 × 30 mL).  The combined organic phases were dried over molecular sieve 3 Å 
(20 beads), filtered and concentrated under reduced pressure.  The residue was dissolved in 
CH2Cl2 (20 mL), split into four 5 mL portions, followed by precipitation through addition of 
tert-butyl methyl ether (45 mL).  After centrifugation (3500 rpm, 5 min), the precipitate was 
harvested, and the precipitation was repeated four times.  The resulting solid was washed by 
treating with MeOH (10 mL) for 5 min in an ultrasonic bath.  The supernatant was aspirated 
after centrifugation (3500 rpm, 5 min).  The solid was dissolved in dioxane (5-10 mL) and 
treated in an ultrasonic bath for 10 min.  The supernatant was then separated from the 
remaining solid which was washed twice with dioxane (10 mL).  The supernatant was divided 
into 5 mL portions and the compound precipitated through addition of tert-butyl methyl ether 
(45 mL).  This purification step was repeated three times.  The resulting solid was dissolved 
in dioxane (10 mL) and frozen with liquid N2, followed by drying at <0.001 mbar.   
 
2.4 Synthesis of 5'deprotected dimer 5.   
 
Compound 5 was prepared following General Protocol A, starting from 4 (5 g, 4.37 mmol), 
and was isolated in a yield of 3.65 g (4.35 mmol, 99%).  
31
P NMR (121.5 MHz, DMSO-d6): δ = 0.59, 0.46, -2.73, -2.95 ppm (mixture of 
diastereomers); (ESI-MS) m/z calcd for C35H37N7O14P2 [M-H]
-
 840.18, obsd 840.18.   
 
2.5 Synthesis of DMT-protected trimer 6.   
 
Following the general protocol B, compound 6 was prepared starting from 5 (0.54 g, 0.64 
mmol) and was obtained as a colorless solid in a yield of 0.87 g (0.55 mmol, 85%). 
 
31
P NMR (121.5 MHz, DMSO-d6): δ = 0.17, -2.18, -2.51, -2.53, -2.65, -2.70 ppm (mixture of 
diastereomers);  (ESI-MS) m/z calcd for C75H74N11O23P3 [M-H]
-
 1588.40, obsd 1588.40.   
 
2.6 Synthesis of trimer 7.   
 
 
Compound 7 was prepared following the General Protocol A, starting from 6 (1.87 g, 1.17 
mmol).  The product was isolated in a yield of 1.45 g (1.13 mmol, 96%). 
31
P NMR (121.5 MHz, DMSO-d6): δ = 0.58, -2.20, -2.55, -2.72, -2.83 ppm (mixture of 
diastereomers); (ESI-MS) m/z calcd for C54H56N11O21P3 [M-H]
-
 1286.27, obsd 1286.27.   
 
2.7 Synthesis of DMT-protected tetramer 1.   
 
 
Following General Protocol B, compound 1 was prepared, starting from 7 (1.5 g, 1.17 mmol) 
and was obtained as an off-white solid in a yield of 1.99 g (1.02 mmol, 87%). 
31
P NMR (121.5 MHz, DMSO-d6): δ = 0.14, -2.03, -2.52, -2.60, -2.63, -2.70 ppm (mixture of 
diastereomers);  (MALDI-TOF-MS) m/z calcd for C88H90N14O30P4 [M-H]
-
 1945.4, obsd 
1944.6.   
2.8 Synthesis of (TCCC)4TBA (2).   
 
 
Hybrid 2 was assembled from the core and the H-phosphonate tetramer using a modification 
of a known method.
[S1,S2]
  Starting from a mixture of TBA (12.4 μmol, 1 equiv), H-
phosphonate tetramer 1 (337 mg, 0.17 mmol, 14 equiv) and molecular sieves (3 Å, ten beads), 
which was dried for 2 h at 45 °C and 0.001 mbar, followed by flushing with argon.  A 
solution of pyridine in CH3CN (3.5 mL, 4:1, v/v) was added, and the resulting mixture was 
cooled to -40 °C.  Diphenyl chlorophosphate (54 µL, 0.26 mmol) was added, and the mixture 
was stirred at -40 °C for 2 h.  Then, a solution of iodine in pyridine (260 µL, 1 M) was added, 
followed by addition of water (16 µL, 0.87 mmol) after 1 min.  The resulting mixture was 
stirred for 10 min at -40 °C and then for 30 min at room temperature.  After addition of 
CH2Cl2 (10 mL), the solution was washed with aqueous sodium thiosulfate (10 mL, 10%, 
w/w), and then with phosphate buffer (9 mL, 0.2 M, pH 7).  The aqueous phase was extracted 
with CH2Cl2 (3 × 10 mL).  The combined organic layers were concentrated in vacuo, the 
residue was coevaporated three times with toluene, and then redissolved in CH2Cl2 (3 mL), 
followed by precipitation with MTBE (45 mL) and isolation by centrifugation.  This 
precipitation was repeated twice, followed by dissolving in CH2Cl2 (5 mL).  The supernatant 
was separated from remaining solid, which was washed with CH2Cl2 (2× 2 mL).  The 
combined organic phases were concentrated under reduced pressure, and the residue was 
washed with MeOH (5 mL).  After the washing step, the crude was used for deprotection.  For 
this, the protected hybrid was dissolved in a mixture of CH2Cl2 (2 mL) and H2O (5 µL, 0.26 
mmol), followed by addition of dichloroacetic acid (4 mL DCA, 6% v/v in CH2Cl2).  After 15 
min, methanol (1.5 mL) was added.  The solution was then concentrated, and the detritylated 
hybrid was isolated by precipitation with MTBE (30 mL), followed by centrifugation, 
redissolving of the separated solid in CH2Cl2/CH3OH (4 mL, 2/1, v/v) and precipitation with 
MTBE (30 mL).  This process was repeated twice.  The remaining protecting groups were 
removed by treating the resulting solid with ammonium hydroxide (25%, 12 mL) for 5 h at 55 
°C. Excess ammonia was removed by passing a stream of N2 over the surface until the 
sample was odourless.  Evaporation of the remaining solution yielded crude 2 (140 mg).  
Cartridge purification on a Sep-Pak C18 cartridge with a gradient of CH3CN (0-25%) in 10 
mM NH4Ac buffer led to elution of 2 at 12-16% CH3CN.  After lyophilization, the title 
compound was obtained in a yield of 54 mg (9.7 μmol, 78%).  A small sample was purified 
by HPLC, using a gradient of CH3CN (5-30% in 45 min) in 10 mM TEAA buffer, with 
elution of 2 at tR = 27.5 min. 
MALDI-TOF-MS m/z calcd for C206H244N44O104P16 [M-H]
-
 5495, obsd 5496.   
3. Additional HPLC chromatogram 
 
 
Figure S1.  HPLC trace of (TCCC)4TBA (2), as obtained after cartridge purification.  Conditions: gradient of 
CH3CN (5-30%) in 45 min; 2 was detected at tR = 27.5 min. 
 
4. Additional MALDI-TOF mass spectra 
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Figure S2.  MALDI-TOF mass spectrum (linear negative mode, TC matrix) of fully protected intermediate 6, as 
used for the subsequent transformation;  -CE denotes loss of cyanoethyl groups, which is believed to occur 
during sample preparation.  
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Figure S3.  MALDI-TOF mass spectrum of fully protected tetramer strand 1; -CE denotes loss of cyanoethyl 
groups (lin. neg., TC matrix). See legend of Figure S2 for other details.    
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Figure S4.  MALDI-TOF mass spectrum of hybrid (TCCC)4TBA (2).   
5. Additional data from assembly studies  
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Figure S5.  UV-melting curve, obtained by cooling the solution of strands forming connecting duplexes 
(compare Table 1 in the main manuscript).   
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Figure S6.  Decrease of UV-absorption recorded after different time points, subsequent to the addition of 2.   
6 UV-Melting curves  
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Figure S7.  UV-Melting curves of assemblies as obtained after 48 h assembly time, measured at a heating rate of 1°C/min; 
(blue: duplex (23:24); red: of (23:24) and 2; green: duplex/hybrid plus CxxC; and purple: duplex-hybrid network plus 
aldolase.  
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Figure S8.  The assembly into three-dimensional networks manifests itself in the hysteresis of heating and cooling curves.  
Overlay of 90 point-smoothed UV-melting curves of connector duplex (9)2 alone and the assembly of this duplex and hybrid 
2, as measured in 10 mM triethylammonium acetate buffer, 150 mM NaCl, and 100 mM MgCl2 at 2 µM hybrid concentration 
and the required four equivalents (8 µM) of the strand forming the connecting duplexes.  Note that the assemblies are slower 
form and slower to disassemble than the connecting duplex alone.   
7. Data on encapsulation of DNA-binding proteins 
Duplexes formed from sequences 31-47 (Figure 3 of the manuscript) were employed to 
generate connecting duplexes.  Table S1, below, lists results obtained with or without either of 
the two small DNA-binding proteins and Figure S8 shows gel analyses of the fractions 
(solid/liquid).  
 
Table S1.  Formation of solids upon assembly of hybrid 2, connecting duplexes of different 
length, and DNA-binding proteins CxxC or Mbd2 into three-dimensional lattices.   
Entry No duplex 
duplex 
[μM] 
hybrid 
[μM] 
CxxC 
[μM] 
Mbd2 
[μM] 
observation 
encapsulation (%) 
1 23:24 40 20 - 1 
solid formation 
partially gel-like, particle-like or solid-like 
≥ 90 
2 23:24 40 20 1 - ≥ 70 
3 29:30 40 20 - 1 ≥ 90 
4 29:30 40 20 1 - ≥ 70 
5 27:28 40 20 - 1 ≥ 90 
6 27:28 40 20 1 - ≥ 70 
7 31:32 40 20 - 1 ≥ 90 
8 31:32 40 20 1 - ≥ 70 
9 33:34 40 20 - 1 ≥ 90 
10 35:36 40 20 - 1 ≥ 90 
11 23:24 40 20 0.25  n. d.  
12 31:32 40 20 - 0.25 quant. 
13 37:38 40 20 0.5 - -- 
14 39:40 40 20 0.5 - 
no formation of solids 
-- 
15 41:42 40 20 0.5 - 
16 (43)2 50 25 - 1 
solid formation 90-80 
17 (44)2 50 25 - 1 
18 (45)2 50 25 - 1 
19 (46)2 50 25 - 1 
20 (47)2 50 25 - 1 
Conditions: 20 mM HEPES, 150 mM NaCl and 10 mM MgCl2 
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Figure S9.  SDS PAGE gels of the solids formed in the assays of Table S 1 and the corresponding supernatant 
solutions.  The numbers are according to the entries of Table S1, L = calibration ladder.   
 
 
8. References for Supporting Information 
                                                 
S1. A. Singh, M. Tolev, C. I. Schilling, S. Bräse, H. Griesser, C. Richert, J. Org. Chem. 2012, 77, 2718-2728.   
S2. A. Schwenger, C. Gerlach, H. Griesser, C. Richert, J. Org. Chem. 2014, 79, 11558-11566.  
